← Eichor
Condition: Telangiectasia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Telangiectasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Phase N/A · 1 location(s) · Imperial College London · NCT00230620A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05010031Immunological Effects of Iron Supplementation in HHT Disease
NA · 1 location(s) · Hospices Civils de Lyon · NCT07111598Institutional Registry of Haemorrhagic Hereditary Telangiectasia
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT01761981Topical TOR-582 Treatment of Epistaxis in HHT
Phase 1 · 1 location(s) · Columbia University · NCT07667413Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Phase 4 · 1 location(s) · Chang Gung Memorial Hospital · NCT06520410Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study
Phase N/A · 36 location(s) · Hospices Civils de Lyon · NCT04194619Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Phase N/A · 16 location(s) · Cure HHT · NCT06259292Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07371663Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)
Phase 1/Phase 2 · 1 location(s) · Timothy Yu · NCT07215416A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 79 location(s) · Artios Pharma Ltd · NCT04657068Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NA · 17 location(s) · Danish Breast Cancer Cooperative Group · NCT03646955Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Phase 1/Phase 2 · 23 location(s) · National Cancer Institute (NCI) · NCT05691491Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00874783Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
NA · 18 location(s) · University Hospital, Clermont-Ferrand · NCT05641142Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia
Phase N/A · 1 location(s) · University Hospital, Essen · NCT04469517The Cancer of the Pancreas Screening-5 CAPS5)Study
Phase 3 · 9 location(s) · Johns Hopkins University · NCT02000089Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device
NA · 1 location(s) · St. Antonius Hospital · NCT07414446Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
Phase 2 · 3 location(s) · Dr. Romain Lazor · NCT04976036Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Phase N/A · 1 location(s) · Imperial College London · NCT00230685Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Phase 4 · 26 location(s) · Neurotech Pharmaceuticals · NCT06971939DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
Phase 1/Phase 2 · 5 location(s) · Diagonal Therapeutics, Inc. · NCT07623525Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiect
NA · 1 location(s) · Ain Shams University · NCT07678697
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.